Ultherapy® is a non-invasive treatment cleared by the FDA to lift skin.
Tissue laxity is largely the result of structural weakening in the skin’s foundation (SMAS/Platysma) at approximately 4.5mm deep. Prior to Ultherapy®, this layer was only accessible during a surgical facelift.
The Ultherapy® procedure stimulates collagen production by delivering focused ultrasound energy to the skin’s foundational layer to non-invasively target the same deep tissue planes as a modern facelift —without cutting or disrupting the surface of the skin.
The Ulthera® System is the only non-invasive device that allows clinicians to see where they’re treating. Using Ulthera’s patented DeepSEE® technology, the system provides real-time ultrasound visualization of the skin down to 8mm. This “See & Treat” technology lets clinicians verify energy is being delivered at the correct tissue depth , ensuring the treatment energy is delivered to where it will be most beneficial. This energy triggers a natural response under the skin, jumpstarting the regenerative process that produces fresh, new collagen.